SHP-1 phosphatase acts as a coactivator of PCK1 transcription to control gluconeogenesis

Area of Science:

• Biochemistry
• Molecular Biology
• Metabolic Regulation

Background:

• Protein-tyrosine phosphatase SHP-1 (PTPN6) is known to negatively regulate insulin signaling.
• Its precise role in hepatic glucose metabolism and systemic glucose control requires further elucidation.

Purpose of the Study:

• To investigate the novel mechanism by which SHP-1 influences hepatic glucose metabolism.
• To determine the role of SHP-1 in the transcriptional regulation of gluconeogenesis.

Main Methods:

• Co-immunoprecipitation assays
• Chromatin immunoprecipitation sequencing (ChIP-seq)
• In silico analysis
• Gluconeogenesis assays

Main Results:

• SHP-1 acts as a coactivator for phosphoenolpyruvate carboxykinase 1 (PCK1) gene transcription, increasing liver gluconeogenesis.
• SHP-1 is recruited to PCK1 gene regulatory regions, interacting with RNA polymerase II.
• SHP-1 recruitment depends on its association with transcription factor STAT5, impacting PCK1 mRNA levels and gluconeogenesis.

Conclusions:

• SHP-1 plays a novel nuclear role as a key transcriptional regulator of hepatic gluconeogenesis.
• This study identifies a new mechanism for SHP-1 in metabolic control.
• SHP-1 and STAT5 are crucial for regulating PCK1 gene expression and hepatic glucose production.